The San Jose-based firm, founded in 2008, invests in seed-stage, early-stage, and later-stage companies in biotech, healthcare, and IT technology. With $150 million AUM, it seeks to invest in revolutionary technology sectors such as therapeutics, diagnostics, and TMT. HEDA Ventures is committed to helping entrepreneurs build world-changing businesses that create new market opportunities and change the world.